Oral Solid Dose Formulation Capabilities Updates

1. Thermo Fisher Scientific Capabilities Update August 2026: Oral Solid Dose Formulation 8/25/2026

   Explore proven strategies and end-to-end expertise for overcoming OSD formulation challenges, reducing development risk, and accelerating therapies to patients.

2. Mikart Capabilities Update August 2026: Oral Solid Dose Formulation 8/24/2026

   Learn how early formulation, analytical, and process decisions reduce scale-up risk, strengthen technology transfer, and support successful oral solid dose commercialization.

3. Recipharm 8/24/2026

   Our development approach is designed to help you move faster from early formulation work to manufacturing readiness and transform complex formulation challenges into more predictable development outcomes.

4. Alcami Capabilities Update August 2026: Oral Solid Dose Formulation 8/24/2026

   Global pharma companies can improve flexibility by separating blister production from final market packaging, helping balance demand, reduce inventory risk, and meet local

5. Altasciences Capabilities Update August 2026: Oral Solid Dose Formulation 8/24/2026

   Experts distinguish drug substance from drug product and explore how different molecular modalities—including small molecules, peptides, biologics, and cell therapies—require distinct formulation and dosage form strategies.